Free Writing Prospectus
Filed Pursuant to Rule 433
Reg. Statement No. 333-195645
Pricing Term Sheet
| Issuer: | Barclays PLC | |
| Notes: | USD 2bn 2.75% Fixed Rate Senior Notes due 2019 | |
| Expected Issue Ratings1: | A3 (Moody’s) / A- (S&P) / A (Fitch) | |
| Status: | Senior Debt / Unsecured | |
| Legal Format: | SEC registered | |
| Principal Amount: | USD 2,000,000,000 | |
| Trade Date: | November 3, 2014 | |
| Settlement Date: | November 10, 2014 (T+5) | |
| Maturity Date: | November 8, 2019 | |
| Coupon: | 2.75% | |
| Interest Payment Dates: | Semi-annually in arrear on May 8 and November 8 in each year, commencing on May 8, 2015 (short first interest period) and ending on the Maturity Date | |
| Coupon Calculation: | 30/360, following, unadjusted | |
| Business Days: | New York, London | |
| U.K. Bail-in Power Acknowedgement: | Yes. See section entitled “Description of Senior Notes—Agreement with Respect to the Exercise of U.K. Bail-in Power” in the Preliminary Prospectus Supplement dated November 3, 2014 (the “Preliminary Prospectus Supplement”). | |
| Tax Redemption | If there is a Tax Event (as defined in the Preliminary Prospectus Supplement), the Issuer may, at its option, at any time, redeem the notes, in whole but not in part, at a redemption price equal to 100% of their principal amount, together with any accrued but unpaid interest to (but excluding) the date fixed for redemption, as further described and subject to the conditions specified in the Preliminary Prospectus Supplement. | |
| Benchmark Treasury: | T 1 1⁄2 10/31/19 | |
| Spread to Benchmark: | 120 bps | |
| Reoffer Yield: | 2.826% | |
| Issue Price: | 99.648% | |
| Underwriting Discount: | 0.325% | |
| Net Proceeds: | USD 1,986,460,000 | |
| Sole Bookrunner: | Barclays Capital Inc. | |
| 1 | Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time. |
| Co-managers: | Blaylock Beal Van, LLC; BMO Capital Markets Corp.; Capital One Securities, Inc.; CIBC World Markets Corp.; Mischler Financial Group, Inc.; Mizuho Securities USA Inc.; Multi-Bank Securities, Inc.; PNC Capital Markets LLC; Santander Investment Securities Inc; Scotia Capital (USA) Inc.; SMBC Nikko Securities America, Inc.; SunTrust Robinson Humphrey, Inc.; TD Securities (USA) LLC; Telsey Advisory Group LLC; The Korea Development Bank; Toussaint Capital Partners, LLC; U.S. Bancorp Investments, Inc.; Wells Fargo Securities, LLC. | |
| Risk Factors: | An investment in the notes involves risks. See “Risk Factors” section beginning on page S-11 of the Preliminary Prospectus Supplement. | |
| Denominations: | USD 200,000 and integral multiples of USD 1,000 in excess thereof | |
| ISIN/CUSIP: | US06738EAD76 / 06738EAD7 | |
| Settlement: | DTC; Book-entry; Transferable | |
| Documentation: | To be documented under the Issuer’s shelf registration statement on Form F-3 (No. 333-195645) and to be issued pursuant to the Senior Debt Indenture expected to be entered into on November 10, 2014 between the Issuer and The Bank of New York Mellon acting through its London Branch, as trustee (the “Trustee”) | |
| Listing: | We will apply to list the notes on the New York Stock Exchange | |
| Governing Law: | New York law | |
| Definitions: | Unless otherwise defined herein, all capitalized terms have the meaning set forth in the Preliminary Prospectus Supplement | |
The issuer has filed a registration statement (including a prospectus dated May 2, 2014 (the “Prospectus”) and the Preliminary Prospectus Supplement) with the U.S. Securities and Exchange Commission (“SEC”) for this offering. Before you invest, you should read the Prospectus and the Preliminary Prospectus Supplement for this offering in that registration statement, and other documents the Issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by searching the SEC online database (EDGAR®) at www.sec.gov. Alternatively, you may obtain a copy of the Prospectus and the Preliminary Prospectus Supplement from Barclays Capital Inc. by calling 1-888-603-5847.